62005 Characterizing suspected and confirmed drug-resistant dermatophytosis through the launch of the AAD/ILDS Drug Resistant Dermatophytes Registry

Document Type

Conference Proceeding

Publication Date

9-1-2025

Publication Title

J Am Acad Dermatol

Abstract

Introduction: Dermatophytes are a common cause of hair, skin, and nail fungal infections, often due to the Trichophyton genus. Over the last decade, an increasing number of antimicrobial-resistant superficial fungal infections caused by T. indotineae and terbinafine-resistant T. rubrum have been identified, leading to severe and often widespread lesions [1]. Drug-resistant dermatophyte outbreaks have been reported in Southeast Asia, Europe, and more recently North America [2,3]. In response to the growing global concern of drug-resistant dermatophytosis, the American Academy of Dermatology (AAD) and International League of Dermatological Societies (ILDS) added a new Drug Resistant Dermatophytes Registry in July 2024 to the existing “AAD/ILDS Dermatology COVID-19, mpox, and Emerging Infections Registry.” Methods and Results: The AAD/ILDS registry was established in April 2020 to collate cases of COVID-19 cutaneous manifestations and was subsequently expanded in August 2022 to include dermatologic manifestations of mpox and mpox/smallpox-related vaccine reactions. The registry will continue to collect COVID-19- and mpox- associated cases, along with suspected and confirmed drug-resistant dermatophyte cases. As of September 2024, this registry has amassed over 2,800 total entries, including new entries of dermatophytosis. Patient demographics, dermatologic and medical history, exposures and contacts, clinical presentation, and treatment are collected via a 5-7 minute REDCap survey of healthcare providers. Conclusion: The AAD/ILDS Dermatology COVID-19, mpox, and Emerging Infections Registry played a significant role in allowing the dermatology community to better understand COVID-19 and mpox infection. With the addition of the dermatophyte registry, we hope to gain further insight into the emerging infectious threat of drug-resistant dermatophytes.

Volume

93

First Page

AB145

Find It @ Sladen

Share

COinS